Patents Assigned to Lica Pharmaceuticals A/S
  • Patent number: 7642367
    Abstract: The invention provides novel diamino-functionalized chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic and bacteriostatic agents.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: January 5, 2010
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Simon Feldbæk Nielsen, Kristian Schønning, Hasse Kromann, Thomas Boesen, Mogens Larsen
  • Patent number: 7423181
    Abstract: The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: September 9, 2008
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Simon Feldbæk Nielsen, Thomas Boesen, Mogens Larsen, Mette Bjerg Nielsen, Hasse Kromann
  • Publication number: 20080027075
    Abstract: The present invention provides novel quaternary amino-functional chalcone derivatives and analogues exhibiting interesting antibacterial activity. The compounds have the general formula (Y1)m—Ar1(X1)—C(=O)VAr2(X2)?(Y2)p (I), wherein V designates —CH2—CH2—, —CH?CH— or —C?C—; Ar1 and Ar2 independently are aryl and heteroaryl; m=0, 1, 2, p=0, 1, 2, m+p>0; each Y1 and Y2 independently is -Z—N+(R1)(R2)R4 Q? (A); —NR3-Z—N+(R1)(R2)R4 Q? (B), or —O-Z—N+(R1)(R2)R4 Q? (C), R1, R2, R3, R4, X1, X2 are substituents, and Q? is an anion. The present invention also relates to the compounds for use as pharmaceutically active agents, in particular against bacterial infections (such as Gram-negative and Gram-positive bacteria, including antibiotic-sensitive or resistant strains), and in the medical treatment of bacterial infections in mammals.
    Type: Application
    Filed: October 28, 2004
    Publication date: January 31, 2008
    Applicant: Lica Pharmaceuticals A/S
    Inventor: Simon Feldbaek Nielsen
  • Publication number: 20050227990
    Abstract: The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 13, 2005
    Applicant: Lica Pharmaceuticals A/S
    Inventors: Simon Nielsen, Thomas Boesen, Mogens Larsen, Mette Bjerg Nielsen, Hasse Kromann
  • Patent number: 6603046
    Abstract: The invention is drawn to novel bis-aromatic a,&bgr;-unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: August 5, 2003
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Arsalan Kharazmi, Søren Brøgger Christensen, Chen Ming, Thor Grundtvig Theander